Transcriptional control of innate lymphoid cells

European Journal of Immunology

Volumn 42, Issue 8, 2012, Pages 1916-1923

  Mjösberg, Jenny ^a   Bernink, Jochem ^a   Peters, Charlotte ^a   Spits, Hergen ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 5; NOTCH RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3;

CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TH17 CELL; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INHIBITOR OF DIFFERENTIATION PROTEIN 2; LYMPHOCYTES; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84864777210     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242639     Document Type: Review

References (68)

1. Spits, H. and Cupedo, T., Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 2012. 30: 647-675.
2. Spits, H. and Di Santo, J. P., The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
3. Scandella, E., Bolinger, B., Lattmann, E., Miller, S., Favre, S., Littman, D. R., Finke, D., Luther, S. A., Junt, T. and Ludewig, B., Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 2008. 9: 667-675.
4. Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G., Doering, T. A., Angelosanto, J. M., et al., Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 2011. 12: 1045-1054.
5. Eberl, G., Marmon, S., Sunshine, M. J., Rennert, P. D., Choi, Y. and Littman, D. R., An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 2004. 5: 64-73.
6. Wong, S. H., Walker, J. A., Jolin, H. E., Drynan, L. F., Hams, E., Camelo, A., Barlow, J. L., et al., Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 2012. 13: 229-236.
7. Kee, B. L., E and ID proteins branch out. Nat. Rev. Immunol. 2009. 9: 175-184.
8. Barndt, R. J., Dai, M. and Zhuang, Y., Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol. Cell Biol. 2000. 20: 6677-6685.
9. Schotte, R., Dontje, W., Nagasawa, M., Yasuda, Y., Bakker, A. Q., Spits, H. and Blom, B., Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development. J. Immunol. 2010. 184: 6670-6679.
10. Cisse, B., Caton, M. L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., et al., Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008. 135: 37-48.
11. Nagasawa, M., Schmidlin, H., Hazekamp, M. G., Schotte, R. and Blom, B., Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol. 2008. 38: 2389-2400.
12. Boos, M. D., Yokota, Y., Eberl, G. and Kee, B. L., Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 2007. 204: 1119-1130.
13. Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S. and Gruss, P., Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999. 397: 702-706.
14. Satoh-Takayama, N., Lesjean-Pottier, S., Vieira, P., Sawa, S., Eberl, G., Vosshenrich, C. A. and Di Santo, J. P., IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46 +cell subsets from Id2-dependent precursors. J. Exp. Med. 2010. 207: 273-280.
15. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., et al., Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2009. 463: 540-544.
16. Heemskerk, M. H., Blom, B., Nolan, G., Stegmann, A. P., Bakker, A. Q., Weijer, K., Res, P. C. and Spits, H., Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 1997. 186: 1597-1602.
17. Jaleco, A. C., Stegmann, A. P., Heemskerk, M. H., Couwenberg, F., Bakker, A. Q., Weijer, K. and Spits, H., Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3. Blood 1999. 94: 2637-2646.
18. Spits, H., Couwenberg, F., Bakker, A. Q., Weijer, K. and Uittenbogaart, C. H., Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 2000. 192: 1775-1784.
19. Carotta, S., Pang, S. H., Nutt, S. L. and Belz, G. T., Identification of the earliest NK-cell precursor in the mouse BM. Blood 2011. 117: 5449-5452.
20. Cherrier, M., Sawa, S. and Eberl, G., Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells. J. Exp. Med. 2012.
21. Beck, K., Peak, M. M., Ota, T., Nemazee, D. and Murre, C., Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 2009. 206: 2271-2284.
22. Aliahmad, P. and Kaye, J., Development of all CD4 T lineages requires nuclear factor TOX. J. Exp. Med. 2008. 205: 245-256.
23. Aliahmad, P., de la Torre, B. and Kaye, J., Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 2010. 11: 945-952.
24. Aliahmad, P., Seksenyan, A. and Kaye, J., The many roles of TOX in the immune system. Curr. Opin. Immunol. 2012. 24: 173-177.
25. Cupedo, T., Crellin, N. K., Papazian, N., Rombouts, E. J., Weijer, K., Grogan, J. L., Fibbe, W. E., et al., Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 2009. 10: 66-74.
26. van de Pavert, S. A. and Mebius, R. E., New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 2010. 10: 664-674.
27. Tsuji, M., Suzuki, K., Kitamura, H., Maruya, M., Kinoshita, K., Ivanov, II, Itoh, K., et al., Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008. 29: 261-271.
28. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. and Flavell, R. A., Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008. 29: 947-957.
29. Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, II, Littman, D. R. and O'Shea, J. J., Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009. 206: 35-41.
30. Satoh-Takayama, N., Vosshenrich, C. A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J. J., et al., Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008. 29: 958-970.
31. Luci, C., Reynders, A., Ivanov, II, Cognet, C., Chiche, L., Chasson, L., Hardwigsen, J., et al., Influence of the transcription factor RORgammat on the development of NKp46 +cell populations in gut and skin. Nat. Immunol. 2009. 10: 75-82.
32. Hughes, T., Becknell, B., McClory, S., Briercheck, E., Freud, A. G., Zhang, X., Mao, H., et al., Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 2009. 113: 4008-4010.
33. Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T. and Spits, H., Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 2010. 207: 281-290.
34. Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K., Doherty, J. M., et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722-725.
35. Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C. and Diefenbach, A., RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009. 10: 83-91.
36. Simmons, C. P., Clare, S., Ghaem-Maghami, M., Uren, T. K., Rankin, J., Huett, A., Goldin, R., et al., Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 2003. 71: 5077-5086.
37. Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., et al., Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008. 14: 282-289.
38. Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A. and Artis, D., CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011. 34: 122-134.
39. Crellin, N. K., Trifari, S., Kaplan, C. D., Satoh-Takayama, N., Di Santo, J. P. and Spits, H., Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010. 33: 752-764.
40. Hughes, T., Becknell, B., Freud, A. G., McClory, S., Briercheck, E., Yu, J., Mao, C., Giovenzana, C., Nuovo, G., Wei, L., Zhang, X., Gavrilin, M. A., Wewers, M. D. and Caligiuri, M. A., Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010. 32: 803-814.
41. Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, II, Littman, D. R., Maloy, K. J. and Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010. 464: 1371-1375.
42. Jetten, A. M., Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal 2009. 7: e003.
43. Wang, Y., Kumar, N., Crumbley, C., Griffin, P. R. and Burris, T. P., A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys Acta 2010. 1801: 917-923.
44. Solt, L. A., Griffin, P. R. and Burris, T. P., Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics. Curr. Opin. Lipidol. 2010. 21: 204-211.
45. Ivanov, II, McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. and Littman, D. R., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 1121-1133.
46. Michel, M. L., Mendes-da-Cruz, D., Keller, A. C., Lochner, M., Schneider, E., Dy, M., Eberl, G. and Leite-de-Moraes, M. C., Critical role of ROR-gammat in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 2008. 105: 19845-19850.
47. Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D., et al., In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 2008. 205: 1381-1393.
48. Veldhoen, M. and Duarte, J. H., The aryl hydrocarbon receptor: fine-tuning the immune-response. Curr. Opin. Immunol. 2010. 22: 747-752.
49. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C. and Stockinger, B., The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008. 453: 106-109.
50. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., et al., Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008. 453: 65-71.
51. Nakahama, T., Kimura, A., Nguyen, N. T., Chinen, I., Hanieh, H., Nohara, K., Fujii-Kuriyama, Y. and Kishimoto, T., Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc. Natl. Acad. Sci. U. S. A. 2011. 108: 14222-14227.
52. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. and Spits, H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009. 10: 864-871.
53. Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A. R., Grigorieva, E. F., Wilhelm, C. and Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011. 147: 629-640.
54. Qiu, J., Heller, J. J., Guo, X., Chen, Z. M., Fish, K., Fu, Y. X. and Zhou, L., The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2011. 36: 92-104.
55. Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C. and Diefenbach, A., Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011. 334: 1561-1565.
56. Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., et al., AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2011. 13: 144-151.
57. Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H. J., Langa, F., Di Santo, J. P. and Eberl, G., Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010. 330: 665-669.
58. Possot, C., Schmutz, S., Chea, S., Boucontet, L., Louise, A., Cumano, A. and Golub, R., Notch signaling is necessary for adult, but not fetal, development of RORgammat(+) innate lymphoid cells. Nat. Immunol. 2011. 12: 949-958.
59. Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S., et al., New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 2002. 169: 443-453.
60. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., et al., IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001. 15: 985-995.
61. Price, A. E., Liang, H. E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J. and Locksley, R. M., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. U. S. A. 2010. 107: 11489-11494.
62. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., Bucks, C., et al., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
63. Halim, T. Y., Krauss, R. H., Sun, A. C. and Takei, F., Lung natural helper cells are a critical source of th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012. 36: 451-463.
64. Yang, Q., Saenz, S. A., Zlotoff, D. A., Artis, D. and Bhandoola, A., Cutting edge: Natural helper cells derive from lymphoid progenitors. J. Immunol. 2011. 187: 5505-5509.
65. Liang, H. E., Reinhardt, R. L., Bando, J. K., Sullivan, B. M., Ho, I. C. and Locksley, R. M., Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat. Immunol. 2011. 13: 58-66.
66. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., Bucks, C., et al., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010. 464: 1367-1370.
67. Huh, J. R., Leung, M. W., Huang, P., Ryan, D. A., Krout, M. R., Malapaka, R. R., Chow, J., et al., Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 2011. 472: 486-490.
68. Solt, L. A., Kumar, N., Nuhant, P., Wang, Y., Lauer, J. L., Liu, J., Istrate, M. A., et al., Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011. 472: 491-494.